LDS/Medical Tests/Vascular Endothelial Growth Factor (VEGF)

Vascular Endothelial Growth Factor (VEGF)

Vascular endothelial growth factor (VEGF) is a potent angiogenic growth factor that acts as a regulator of both physiological and pathological angiogenesis. It is produced by epithelial, inflammatory, hematopoietic and endothelial cells. VEGF acts on endothelial cells to stimulate angiogenesis and therefore has both paracrine and autocrine functions. VEGF is upregulated by hypoxia and is increased in many conditions including POEMS syndrome, diabetic retinopathy and cancer. POEMS stands for these syndromes: polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes.

VEGF mRNA is highly upregulated in the vast majority of human cancers and appears to be required for tumor growth and survival. Rapid growth creates a hypoxic state within the tumor which stimulates VEGF production, resulting in new vessel formation thereby allowing the tumor to grow. VEGF is also required for the survival and growth of metastatic tumor cells. Due to its function in supporting the growth of both primary tumors and metastasis, VEGF is an attractive pharmacologic target in cancer therapy. Agents that target VEGF such as anti-VEGF antibodies (bevacizumab, ramucirumab), or Fab fragments (ranibizumab), VEGF-receptor mimics (aflibercept), anti-angiogenic tyrosine kinase inhibitors (TKIs) such as sorafenib, sunitinib, pazopanib, axitinib, vandetanib, regorafenib, Lenvatinib and other anti-angiogenesis approaches are being used and evaluated in a variety of cancer types.

Although VEGF concentrations in blood and other body fluids are being evaluated for their potential use in screening, diagnosis and monitoring of multiple cancer types, (sarcomas, non-small cell lung cancer, breast cancer, renal cell carcinoma, hepatocellular carcinoma, thyroid carcinoma, colon cancer and others), it is not widely used clinically, except in the evaluation of patients with POEMS. POEMS syndrome is a rare blood disorder that damages nerves and affects other parts of the body. POEMS stands for symptoms of the condition. Symptoms may include weak legs, trouble breathing, a larger spleen or liver, and skin changes.

VEGF is often elevated in Bartonella infections, which inflame the vasculature and contribute to symptoms like pain, headaches, and neurological changes. VEGF >40 (even within the normal lab range) may suggest Bartonella in the context of chronic biotoxin illness or CIRS. In chronic biotoxin illness (CIRS), VEGF can become suppressed due to long-standing immune dysfunction. So values that appear “normal” may still be clinically significant. VEGF >115 is strongly suggestive of Bartonella involvement. 

  • To diagnose rhabdomyosarcomas
  • As an aid in the diagnosis of POEMS syndrome
  • As an aid in the diagnosis of Bartonella infections related to neurological disorders
Elevated levels of VEGF maybe consistent with POEMS.

6-95 pg/mL

ELISA (Enzyme-linked Immunoassay), automated immunoassay.

Serum (STT tube).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: 30 days
Muscle biopsy, Complete blood count with differential count, Alveolar Rhabdomyosarcoma by RT-PCR, FNAC, Thyroid function tests Comprehensive metabolic panel.
3-5 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login